Does the antibody-based delivery of interleukin-12 to the tumor neovasculature eradicate murine models of cancer in combination with paclitaxel?
The potent antitumor activity of mIL12-F8-F8, studied alone or in combination with paclitaxel in different tumor models, paves the way to the clinical development of the fully human immunocytokine.
Routine submission of histological specimens for analysis and out-patient follow-up are not required following circumcision.